Vaccinations, Variable Risk Lead Payers to End COVID Waivers

Health insurers have begun to phase out the COVID-19 treatment cost-sharing waivers that they have had in place for most of the pandemic. As vaccines have become broadly available in the U.S., insurers are starting to see the novel coronavirus as a “normal” disease — and plan sponsors like Delta Air Lines Inc. are beginning to see health benefits as another means to steer employees toward vaccination.

During most of 2020 and the first half of this year, most carriers took on the full cost of COVID-19 treatment for their fully insured members, waiving copays and other cost sharing. Many self-funded employer plan sponsors did the same. However, both types of health plans have begun to make COVID-19 care a normal health benefit with standard hospitalization and outpatient cost sharing applied.

0 Comments
© 2022 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

golden-gate-bridge
September 23

West Coast Public Sector Plan Sponsors Will Coordinate More Closely Through Purchaser Group

READ MORE
remote-patient-monitoring-and-phone
September 23

Spike in Remote Patient Monitoring During Pandemic Is Driven by a Fraction of Providers

READ MORE
humana-headquarter
September 23

Humana Will Buy One Primary Care Group — and Could Snap Up Another

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today